NCT07763522

Brief Summary

Lumbar disc herniation (LDH) is a common condition that may cause lower limb motor weakness (paresis), particularly affecting ankle dorsiflexion and plantarflexion. Although motor deficits are clinically important and may influence treatment decisions, objective and standardized methods for quantifying the severity of paresis are lacking. Current clinical assessment mainly relies on manual muscle testing, which is subjective and has limited sensitivity, while isokinetic dynamometry, the reference standard for muscle strength assessment, is expensive and impractical for routine clinical use. This prospective validation study aims to evaluate a clinically feasible isometric ankle strength measurement method based on a handheld dynamometer fixed with an external strap to eliminate examiner-dependent resistance. The study will be conducted in two sequential phases. First, validity and reliability of the method will be established in healthy adult volunteers by comparing measurements with those obtained using an isokinetic dynamometer. Second, the method will be applied in patients with LDH-induced lower limb paresis to determine its performance across a broader range of muscle strength values and its clinical applicability. Outcome measures include maximal isometric ankle dorsiflexion and plantarflexion force, time to peak force, manual muscle testing (Medical Research Council scale), patient-reported weakness using a Numeric Rating Scale, Lower Extremity Functional Scale (LEFS) scores, and functional ankle strength tests. Validity will be assessed using correlation analyses and Bland-Altman agreement analysis, while intra- and inter-rater reliability will be evaluated using intraclass correlation coefficients, coefficient of variation, standard error of measurement, and minimum detectable change. The study seeks to establish a reliable, valid, and clinically practical method for objective assessment of ankle muscle strength in patients with LDH-induced paresis. Such a method could improve clinical evaluation, enable objective monitoring of recovery, facilitate future clinical research, and support treatment decision-making.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
70

participants targeted

Target at P50-P75 for not_applicable

Timeline
2mo left

Started Aug 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
enrolling by invitation

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress49%
Aug 2026Dec 2026

First Submitted

Initial submission to the registry

July 8, 2026

Completed
1 month until next milestone

Study Start

First participant enrolled

August 10, 2026

Completed
3 days until next milestone

First Posted

Study publicly available on registry

August 13, 2026

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2026

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2026

Expected
Last Updated

August 13, 2026

Status Verified

August 1, 2026

Enrollment Period

2 months

First QC Date

July 8, 2026

Last Update Submit

August 12, 2026

Conditions

Keywords

dynamometryparesisstrength measurement

Outcome Measures

Primary Outcomes (4)

  • Criterion validity of the isometric handheld dynamometer

    Agreement between the investigational isometric handheld dynamometer (HHD) measurement method and the reference standard isokinetic dynamometer (IKD) for maximal ankle dorsiflexion and plantarflexion strength.

    At baseline (first measurement session; Day 0)

  • Construct validity of the handheld dynamometer

    Correlation of HHD measurements with patient-reported weakness (Numerical Rating Scale), Lower Extremity Functionality Scale questionnaire, manual muscle testing (Medical Research Council grade) and functional ankle performance tests.

    At baseline (first measurement session; Day 0)

  • Intra-rater reliability of the handheld dynamometer

    Test-retest reliability of ankle dorsiflexion and plantarflexion strength measurements obtained by the same examiner.

    At baseline (Day 0) and at the second measurement session, within 7 days after baseline

  • Inter-rater reliability of the handheld dynamometer

    Agreement between measurements performed by different examiners

    At the second measurement session, within 7 days after baseline

Other Outcomes (8)

  • Maximal isometric ankle dorsiflexion strength

    At baseline (first measurement session; Day 0)

  • Maximal isometric ankle plantarflexion strength

    At baseline (first measurement session; Day 0)

  • Time to peak force

    At baseline (first measurement session; Day 0)

  • +5 more other outcomes

Study Arms (1)

Study participant

OTHER

Person participating in validity and reliability assessment

Device: Strength test validity and reliability

Interventions

Ankle dorsiflexion and plantarflexion isometric maximal voluntary contraction strength test

Study participant

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Aged 18-65 years old
  • No pathology affecting ankle dorsiflexion or plantarflexion strength

You may not qualify if:

  • \- Pathology affecting ankle dorsiflexion or plantarflexion strength
  • Second phase
  • Aged 18-65 years old
  • LDH-induced muscle weakness of ankle dorsiflexion or plantarflexion
  • \- No muscle weakness induced by herniated lumbar disc

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Helsinki University Central Hospital

Helsinki, Uusimaa, 00290, Finland

Location

MeSH Terms

Conditions

ParesisIntervertebral Disc Displacement

Condition Hierarchy (Ancestors)

Neurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsSpinal DiseasesBone DiseasesMusculoskeletal DiseasesHerniaPathological Conditions, Anatomical

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

July 8, 2026

First Posted

August 13, 2026

Study Start

August 10, 2026

Primary Completion

October 1, 2026

Study Completion (Estimated)

December 1, 2026

Last Updated

August 13, 2026

Record last verified: 2026-08

Data Sharing

IPD Sharing
Will share

De-identified individual participant data underlying the results reported in the publication, including ankle strength measurements, functional outcome measures, and participant characteristics.

Shared Documents
STUDY PROTOCOL, SAP
Time Frame
10 years after publication
Access Criteria
Researchers who provide a methodologically sound research proposal. Data will be available upon reasonable request to the principal investigator, subject to institutional approval, applicable legislation, and a data sharing agreement.

Locations